* Viemed Healthcare Inc VMD.TO VMD.TO is expected to show
a rise in quarterly revenue when it reports results on May 3.
* The Lafayette, Louisiana-based company is expected to report
a 18.5% increase in revenue to $28.209 million from $23.81
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Viemed Healthcare Inc
is for earnings of 6 cents per share. For the same quarter last
year, the company reported earnings of 11 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Viemed
Healthcare Inc is C$16.46, about 39.9% above its last closing
price of $9.90.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 0.04 0.03 0.12 Beat 300
Sep. 30 2020 0.08 0.08 0.07 Missed -8.7
Jun. 30 2020 0.23 0.23 0.48 Beat 108.7
Mar. 31 2020 0.08 0.08 0.11 Beat 37.5
Dec. 0.07 0.06 Missed -14.3
31 2019
Sep. 30 2019 0.06 0.06 0.07 Beat 16.7
Jun. 30 2019 0.06 0.06 0.05 Missed -16.7
Mar. 31 2019 0.08 0.08 0.05 Missed -37.5
This summary was machine generated April 30 at 20:57 GMT. All
figures in US dollars unless otherwise stated